Viewing Study NCT00546650


Ignite Creation Date: 2025-12-24 @ 5:07 PM
Ignite Modification Date: 2026-02-25 @ 6:44 PM
Study NCT ID: NCT00546650
Status: COMPLETED
Last Update Posted: 2016-02-03
First Post: 2007-10-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
Sponsor: NuPathe Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module